Product Development a Bristol Myers Squibb has an unwavering dedication to developing innovative medicines that transform patients’ lives. Transferring oral and parenteral drug product manufacturing processes for clinical or commercial manufacturing is an essential deliverable from Product Development to maintain delivery of innovative medicines to patients. In the time of SARS-CoV-2/Covid-19 and our fight to combat the pandemic through social distancing and working remotely, hands on manufacturing processes - particularly when transferring the process between organizations - can introduce risk of viral transmission. Our team has employed augmented reality, remote monitoring protocols, and other digital technology to maximize the ability to collaborate remotely, collect data, and transfer information and know-how while mitigating the risk of viral transmission. Several projects at different stages have been de-risked, troubleshot, and otherwise enabled through application of these innovative digital technologies.
Preview Presentation
Presenter(s)
Once the content has been viewed and you have attested to it, you will be able to download and print a certificate for PDH credits.
If you have already viewed this content,
please click here
to login.